Thiazolopyrimidine derivatives as novel class of small molecule tyrosinase inhibitor.

BMC Chem

Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.

Published: November 2023

Tyrosinase, the rate-limiting enzyme of melanogenesis, plays a crucial role in hyperpigmentation. As a result, in this study, a novel class of thiazolopyrimidine derivatives was developed and synthesized as tyrosinase inhibitor. The structure of derivatives was characterized using various spectroscopy techniques, including FTIR, Mass, H-NMR, and C-NMR. Next, the inhibitory activities of all derivatives were examined against tyrosinase, and, 6a as the most potent compound, exhibited an IC value of 28.50 µM. Furthermore, the kinetic study of 6a was performed to better understand the inhibitory mechanism and its type of inhibition. The UV/Vis spectra analysis was also executed to provide valuable evidence supporting the inhibitory mechanism of compound 6a in the context of tyrosinase inhibition. Also, molecular docking and dynamic molecular study of 6a were executed to study its interactions within the enzyme's binding site.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658973PMC
http://dx.doi.org/10.1186/s13065-023-01077-zDOI Listing

Publication Analysis

Top Keywords

thiazolopyrimidine derivatives
8
novel class
8
tyrosinase inhibitor
8
inhibitory mechanism
8
tyrosinase
5
derivatives novel
4
class small
4
small molecule
4
molecule tyrosinase
4
inhibitor tyrosinase
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!